Kestra Medical Technologies, Ltd. (KMTS) Stock Forecast
Data as of Sep 16, 2026Healthcare · Current price $24.80 (+3.20%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Dec 12, 2025 | Matt O'Brien | Piper Sandler | $30.00 | +21.0% |
Top Analysts Covering KMTS
KMTS vs Sector & Market
| Metric | KMTS | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.17 | 2.25 | 2.42 |
| Analyst Count | 6 | 8 | 18 |
| Target Upside | +35.9% | +16187.2% | +19.5% |
| P/E Ratio | -7.90 | 3.80 | 38.67 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-10-31 | $31M | $32M | $32M | 3 |
| 2027-01-31 | $34M | $35M | $35M | 3 |
| 2027-04-30 | $39M | $39M | $39M | 2 |
| 2027-07-31 | $41M | $42M | $42M | 3 |
| 2027-10-31 | $46M | $47M | $47M | 3 |
| 2028-01-31 | $49M | $49M | $50M | 2 |
| 2028-04-30 | $55M | $56M | $56M | 1 |
| 2029-04-30 | $265M | $269M | $271M | 3 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-10-31 | $-0.55 | $-0.55 | $-0.55 | 1 |
| 2027-01-31 | $-0.56 | $-0.56 | $-0.56 | 1 |
| 2027-04-30 | $-0.52 | $-0.52 | $-0.52 | 1 |
| 2027-07-31 | $-0.50 | $-0.49 | $-0.49 | 1 |
| 2027-10-31 | $-0.44 | $-0.44 | $-0.44 | 1 |
| 2028-01-31 | $-0.43 | $-0.42 | $-0.42 | 1 |
| 2028-04-30 | $-0.40 | $-0.40 | $-0.39 | 1 |
| 2029-04-30 | $-1.22 | $-1.21 | $-1.19 | 2 |
Frequently Asked Questions
What is the analyst consensus for KMTS?
The consensus among 6 analysts covering Kestra Medical Technologies, Ltd. (KMTS) is Buy with an average price target of $31.00.
What is the highest price target for KMTS?
The highest price target for KMTS is $30.00, set by Matt O'Brien at Piper Sandler on 2025-12-12.
What is the lowest price target for KMTS?
The lowest price target for KMTS is $30.00, set by Matt O'Brien at Piper Sandler on 2025-12-12.
How many analysts cover KMTS?
6 analysts have issued ratings for Kestra Medical Technologies, Ltd. in the past 12 months.
Is KMTS a buy or sell right now?
Based on 6 analyst ratings, KMTS has a consensus rating of Buy (2.17/5) with a +35.9% upside to the consensus target of $31.00.
What are the earnings estimates for KMTS?
Analysts estimate KMTS will report EPS of $-0.55 for the period ending 2026-10-31, with revenue estimated at $32M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.